Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2016 2
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

5results
Results by year
Filters applied:.Clear all
Page 1
Mepolizumab effectiveness and identification of super-responders in severe asthma.
Harvey ES, Langton D, Katelaris C, Stevens S, Farah CS, Gillman A, Harrington J, Hew M, Kritikos V, Radhakrishna N, Bardin P, Peters M, Reynolds PN, Upham JW, Baraket M, Bowler S, Bowden J, Chien J, Chung LP, Grainge C, Jenkins C,Katsoulotos GP, Lee J, McDonald VM, Reddel HK, Rimmer J, Wark PAB, Gibson PG. Harvey ES, et al. Among authors:katsoulotos gp. Eur Respir J. 2020 May 21;55(5):1902420. doi: 10.1183/13993003.02420-2019. Print 2020 May. Eur Respir J. 2020. PMID:32139455 Free article.
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry.
Thomas D, Harvey ES, McDonald VM, Stevens S, Upham JW, Katelaris CH, Kritikos V, Gillman A, Harrington J, Hew M, Bardin P, Peters M, Reynolds PN, Langton D, Baraket M, Bowden JJ, Bowler S, Chien J, Chung LP, Farah CS, Grainge C, Jenkins C,Katsoulotos GP, Lee J, Radhakrishna N, Reddel HK, Rimmer J, Sivakumaran P, Wark PAB, Gibson PG. Thomas D, et al. Among authors:katsoulotos gp. J Allergy Clin Immunol Pract. 2021 Jul;9(7):2715-2724.e5. doi: 10.1016/j.jaip.2021.01.028. Epub 2021 Feb 3. J Allergy Clin Immunol Pract. 2021. PMID:33545399
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria.
Hew M, Gillman A, Sutherland M, Wark P, Bowden J, Guo M, Reddel HK, Jenkins C, Marks GB, Thien F, Rimmer J,Katsoulotos GP, Cook M, Yang I, Katelaris C, Bowler S, Langton D, Wright C, Bint M, Yozghatlian V, Burgess S, Sivakumaran P, Yan KY, Kritikos V, Peters M, Baraket M, Aminazad A, Robinson P, Jaffe A, Powell H, Upham JW, McDonald VM, Gibson PG. Hew M, et al. Among authors:katsoulotos gp. Clin Exp Allergy. 2016 Nov;46(11):1407-1415. doi: 10.1111/cea.12774. Epub 2016 Jul 22. Clin Exp Allergy. 2016. PMID:27377155
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry.
Gibson PG, Reddel H, McDonald VM, Marks G, Jenkins C, Gillman A, Upham J, Sutherland M, Rimmer J, Thien F,Katsoulotos GP, Cook M, Yang I, Katelaris C, Bowler S, Langton D, Robinson P, Wright C, Yozghatlian V, Burgess S, Sivakumaran P, Jaffe A, Bowden J, Wark PA, Yan KY, Kritikos V, Peters M, Hew M, Aminazad A, Bint M, Guo M. Gibson PG, et al. Among authors:katsoulotos gp. Intern Med J. 2016 Sep;46(9):1054-62. doi: 10.1111/imj.13166. Intern Med J. 2016. PMID:27350385
The Diacylglycerol-dependent translocation of ras guanine nucleotide-releasing protein 4 inside a human mast cell line results in substantial phenotypic changes, including expression of interleukin 13 receptor alpha2.
Katsoulotos GP, Qi M, Qi JC, Tanaka K, Hughes WE, Molloy TJ, Adachi R, Stevens RL, Krilis SA. Katsoulotos GP, et al. J Biol Chem. 2008 Jan 18;283(3):1610-1621. doi: 10.1074/jbc.M707042200. Epub 2007 Nov 16. J生物化学杂志》2008。 PMID:18024961 Free article.